Xen 63 versus Preserflo MicroShunt implant in patients with primary open-angle glaucoma

Xen 63 versus Preserflo MicroShunt implant in patients with primary open-angle glaucoma

Abstract This study compared the efficacy safety profiles of the Xen 63 and Preserflo MicroShunt devices, both standalone, in patients with primary open-angle glaucoma (POAG). It is a retrospective and single-center study conducted on consecutive on patients with medically uncontrolled POAG who unde...

Full description

Bibliographic Details
Main Authors: José María Martínez-de-la-Casa, Antonio Pascual-Santiago, Laura Morales-Fernandez, Federico Saez-Frances, Sofia Garcia-Saenz, Noemi Guemes-Villahoz, Ruben Sanchez-Jean, Carmen Mendez, Julian Garcia-Feijoo
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Xen 63
Preserflo
MicroShunt
Glaucoma
MIGS
IOP
Online Access:https://doi.org/10.1038/s41598-024-81616-3

Internet

https://doi.org/10.1038/s41598-024-81616-3

Similar Items